Skip to Content
Merck
CN
  • Mutagenicity studies with o-tolidine and 4,4'-tetramethyldiaminodiphenylmethane.

Mutagenicity studies with o-tolidine and 4,4'-tetramethyldiaminodiphenylmethane.

Mutation research (1981-07-01)
D H Waalkens, H F Joosten, T D Yih, A Hoekstra
ABSTRACT

This paper confirms the mutagenicity of 2 carcinogenic chemicals, o-tolidine and 4,4'-tetramethyldiaminodiphenylmethane (TDDM). o-Tolidine and TDDM were both tested in the Salmonella/mammalian-microsome test and in the sister-chromatid exchange (SCE) test with rabbit lymphocytes in vitro. The number of revertants was increased in the presence of S9 mix by o-tolidine in the Salmonella typhimurium strains TA98 and TA1538, and by TDDM in strains TA98 and TA100. Both compounds showed weak SCE-inducing activity in cultured rabbit lymphocytes in the absence, but not in the presence, of an exogenous metabolic system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4,4′-Methylenebis(N,N-dimethylaniline), 97.5% (GC)